Tablet Risperidone (6 mg/day) combined with placebo as control group for 8 weeks
Sponsors
Tehran University of Medical Sciences
Conditions
Schizophrenia.
Schizophreniaschizophrenia.
schizophrenia
Phase 3
Minocycline in the treatment of schizophrenia
Active, not recruitingIRCT201202241556N34
Start: 2012-03-05Target: 50Updated: 2018-02-22
Raloxifene in the treatment of schizophrenia
Active, not recruitingIRCT201205131556N42
Start: 2012-06-21Target: 46Updated: 2018-02-22
Desmopressin acetate as an add-on therapy in patients with schizophreni?l
Active, not recruitingIRCT201208071556N45
Start: 2012-09-10Target: 40Updated: 2018-02-22
Raloxifene in men with chronic schizophrenia
Active, not recruitingIRCT201211211556N47
Start: 2012-11-21Target: 46Updated: 2018-02-22
Cilostazol in the treatment of schizophrenia
Active, not recruitingIRCT201407151556N61
Start: 2014-08-01Target: 50Updated: 2018-02-22
L carnosine in patients with schizophrenia
Active, not recruitingIRCT201504211556N75
Start: 2015-05-22Target: 50Updated: 2018-02-22
Vortioxetine as adjunctive treatment of schizophrenia
RecruitingIRCT201710241556N100
Start: 2017-11-09Target: 50Updated: 2018-02-22
Phase 4
Unknown Phase
Acetaminophen in the treatment of schizophrenia
Active, not recruitingIRCT201410251556N67
Start: 2014-11-03Target: 50Updated: 2018-02-22
Citicoline as adjunctive treatment of negative symptoms in patients with schizophrenia
Active, not recruitingIRCT201604051556N87
Start: 2016-04-20Target: 50Updated: 2018-02-22